FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-associated death worldwide. Indeed, despite the benefit of sorafenib in the treatment of some patients with HCC, the majority of these patients have a poor response to or intolerance of sorafenib, resulting in further tumor progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhi, Yingru, Abudoureyimu, Mubalake, Zhou, Hao, Wang, Ting, Feng, Bing, Wang, Rui, Chu, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514537/
https://www.ncbi.nlm.nih.gov/pubmed/31082791
http://dx.doi.org/10.1016/j.omtn.2019.04.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514537/
https://www.ncbi.nlm.nih.gov/pubmed/31082791
http://dx.doi.org/10.1016/j.omtn.2019.04.008

Ejemplares similares